Medtronic Stock Price, News & Analysis (NYSE:MDT)

$82.00 0.73 (0.90 %)
(As of 12/13/2017 09:43 AM ET)
Previous Close$81.27
Today's Range$81.80 - $82.69
52-Week Range$69.35 - $89.72
Volume4.97 million shs
Average Volume4.95 million shs
Market Capitalization$110.00 billion
P/E Ratio17.51
Dividend Yield2.27%
Beta1

About Medtronic (NYSE:MDT)

Medtronic logoMedtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:MDT
CUSIP58505510
Phone353-1438-1700

Debt

Debt-to-Equity Ratio0.50%
Current Ratio2.40%
Quick Ratio2.05%

Price-To-Earnings

Trailing P/E Ratio17.51
Forward P/E Ratio17.19
P/E Growth2.24

Sales & Book Value

Annual Sales$29.71 billion
Price / Sales3.74
Cash Flow$6.87 per share
Price / Cash11.93
Book Value$38.11 per share
Price / Book2.15

Profitability

Trailing EPS$3.65
Net Income$4.03 billion
Net Margins16.93%
Return on Equity12.63%
Return on Assets6.51%

Miscellaneous

Employees91,000
Outstanding Shares1,353,500,000

Medtronic (NYSE:MDT) Frequently Asked Questions

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Friday, December 8th. Stockholders of record on Friday, December 29th will be given a dividend of $0.46 per share on Friday, January 19th. This represents a $1.84 annualized dividend and a dividend yield of 2.24%. The ex-dividend date is Thursday, December 28th. View Medtronic's Dividend History.

How will Medtronic's stock buyback program work?

Medtronic announced that its board has initiated a share repurchase program on Thursday, October 5th 2017, which permits the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 49% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's board believes its stock is undervalued.

How were Medtronic's earnings last quarter?

Medtronic PLC (NYSE:MDT) released its earnings results on Tuesday, November, 21st. The medical technology company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.08. The medical technology company had revenue of $7.05 billion for the quarter, compared to analysts' expectations of $7.05 billion. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The company's revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.12 earnings per share. View Medtronic's Earnings History.

When will Medtronic make its next earnings announcement?

Medtronic is scheduled to release their next quarterly earnings announcement on Tuesday, February, 20th 2018. View Earnings Estimates for Medtronic.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its second quarter earnings guidance on Wednesday, November, 8th. The company provided earnings per share guidance of $1.04 for the period, compared to the Thomson Reuters consensus estimate of $0.94. The company issued revenue guidance of ~$7.1 billion, compared to the consensus revenue estimate of $6.87 billion.

Where is Medtronic's stock going? Where will Medtronic's stock price be in 2017?

23 brokerages have issued 1-year price targets for Medtronic's shares. Their predictions range from $78.00 to $99.00. On average, they anticipate Medtronic's share price to reach $88.75 in the next year. View Analyst Ratings for Medtronic.

What are Wall Street analysts saying about Medtronic stock?

Here are some recent quotes from research analysts about Medtronic stock:

  • 1. According to Zacks Investment Research, "Medtronic exited the fiscal second quarter on a mixed note. While the company demonstrated improved segmental performances at CER, escalating costs and expenses continue to weigh on the bottom line. Unfavorable currency translation also acted as a dampener. On the bright side, all major business groups contributed to solid top-line growth at CER, which highlighted sustainability across groups and regions, in addition to displaying successful integration and achievement of synergy targets. We are also encouraged by the solid growth trend in the United States as well as healthy global acceptance of its advanced therapies. The recent receipt of FDA approval and commercial launch of Azure pacemakers with BlueSync technology buoy optimism. Apart from product innovation, the company is focusing on geographical diversification of its businesses. The stabilizing trend in the global Cardiac Rhythm & Heart Failure (CRHF) market is another upside." (11/23/2017)
  • 2. Needham & Company LLC analysts commented, "On 11/8/17, MDT preannounced F2Q18 revenue of $7.050B (up 3% organic Y/Y) vs. consensus of $6.897M. The impact from Hurricane Maria was revised down to ~$60M from ~$250M, which equates to ~1% in quarterly revenue growth and ~$0.03 in non-GAAP EPS. MDT did not update its FY18 revenue or EPS guidance in the press release but did reaffirm F2Q18 non-GAAP EPS growth of flat to slightly up, excluding the ~$0.03 headwind. MDT is scheduled to report full F2Q18 results on 11/21/17 and we intend to wait until then to update our model." (11/9/2017)
  • 3. BTIG Research analysts commented, "At last Friday's American College of Cardiology (ACC) meeting, two-year data on MDT's SURTAVI trial for intermediate-risk was presented. At the two-year mark, all cause death/stroke were similar for TAVR using MDT's valves (12.6%) vs. surgery (14%) though use of TAVR reduced 30-day strokes, kidney injury, afib, and hospital stay. While we were surprised TAVR was not superior to surgery as in other trials, it seems surgical results improved. Still, TAVR is at least as good with less invasiveness. While not the same trials, investors have tried to compare MDT's CoreValve to Edwards' (EW, Neutral) SAPIEN 3 based on available data. At 1 year, all-cause death and stroke were equivalent at 8.1% for CoreValve and 8.4% for SAPIEN 3. Overall, patient selection (EW's intermediate risk pool may have had more comorbidities) and device design (MDT mainly used its older valve) make it tough to directly compare both trials; but we believe the valves are essentially equivalent and either one should be chosen over surgery." (3/20/2017)
  • 4. Wedbush analysts commented, "Medtronic's broad product portfolio allows the company to navigate through temporary disruptions it might encounter in any given business unit, and today's FY3Q17 earnings results showcased management's ability to leverage its size and recover more quickly than we had expected from its disappointing FY2Q17 performance reported in November. With MDT's share price having mostly recovered from the post FY2Q17 selloff, we believe current valuation levels adequately reflect MDT's risk/reward profile and prefer to wait on the sidelines for a better entry point. ' FY3Q17 revenue of $7,283 million (+6% yr/yr, ex-FX) beat consensus revenue estimate of $7,220 million. Revenue from all four segments exceeded consensus, with the biggest contribution from Minimally Invasive Therapies Group (MTIG) and Diabetes' Our $85 PT is based on applying a 16x P/E multiple on our MDT forward EPS estimate, 12 months hence." (2/22/2017)

Are investors shorting Medtronic?

Medtronic saw a decrease in short interest in the month of November. As of November 30th, there was short interest totalling 8,678,569 shares, a decrease of 29.9% from the November 15th total of 12,387,732 shares. Based on an average daily volume of 6,051,050 shares, the days-to-cover ratio is currently 1.4 days. Currently, 0.6% of the company's stock are short sold.

Who are some of Medtronic's key competitors?

Who owns Medtronic stock?

Medtronic's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Artisan Partners Limited Partnership (1.76%), Barrow Hanley Mewhinney & Strauss LLC (1.22%), Bank of New York Mellon Corp (1.08%), Wells Fargo & Company MN (0.91%), Ameriprise Financial Inc. (0.84%) and American Century Companies Inc. (0.67%). Company insiders that own Medtronic stock include Bryan C Hanson, Carol A Surface, Gary Lee Ellis, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, James T Lenehan, Kendall J Powell, Omar Ishrak, Richard H Anderson, Richard Kuntz, Robert C Pozen and Shirley A Jackson. View Institutional Ownership Trends for Medtronic.

Who sold Medtronic stock? Who is selling Medtronic stock?

Medtronic's stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Capital International Investors, APG Asset Management N.V., Capital Guardian Trust Co., Vaughan Nelson Investment Management L.P., Capital Bank & Trust Co, Country Trust Bank and California State Teachers Retirement System. Company insiders that have sold Medtronic company stock in the last year include Bryan C Hanson, Hoedt Rob Ten, Hooman Hakami and Omar Ishrak. View Insider Buying and Selling for Medtronic.

Who bought Medtronic stock? Who is buying Medtronic stock?

Medtronic's stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, American Century Companies Inc., Asset Management One Co. Ltd., Ameriprise Financial Inc., Stifel Financial Corp, Allianz Asset Management GmbH, Boston Partners and Diamond Hill Capital Management Inc.. Company insiders that have bought Medtronic stock in the last two years include James T Lenehan, Richard H Anderson and Robert C Pozen. View Insider Buying and Selling for Medtronic.

How do I buy Medtronic stock?

Shares of Medtronic can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medtronic's stock price today?

One share of Medtronic stock can currently be purchased for approximately $82.00.

How big of a company is Medtronic?

Medtronic has a market capitalization of $110.00 billion and generates $29.71 billion in revenue each year. The medical technology company earns $4.03 billion in net income (profit) each year or $3.65 on an earnings per share basis. Medtronic employs 91,000 workers across the globe.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]


MarketBeat Community Rating for Medtronic (MDT)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  859 (Vote Outperform)
Underperform Votes:  554 (Vote Underperform)
Total Votes:  1,413
MarketBeat's community ratings are surveys of what our community members think about Medtronic and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medtronic (NYSE:MDT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.622.562.612.59
Ratings Breakdown: 0 Sell Rating(s)
10 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
12 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
11 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
11 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $89.70$88.78$89.74$89.39
Price Target Upside: 10.37% upside14.10% upside12.53% upside5.06% upside

Medtronic (NYSE:MDT) Consensus Price Target History

Price Target History for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2017ArgusUpgradeHold -> Buy$81.27 -> $95.00LowView Rating Details
12/12/2017BMO Capital MarketsBoost Price TargetOutperform$94.00LowView Rating Details
11/23/2017Jefferies GroupReiterated RatingBuy$99.00N/AView Rating Details
11/22/2017Northland SecuritiesReiterated RatingHold$80.00N/AView Rating Details
11/22/2017OppenheimerReiterated RatingBuy$94.00N/AView Rating Details
11/22/2017Stifel NicolausBoost Price TargetHold$83.00 -> $85.00N/AView Rating Details
11/19/2017SunTrust BanksSet Price TargetBuy$92.00N/AView Rating Details
11/9/2017Needham & Company LLCReiterated RatingBuy$94.00N/AView Rating Details
11/3/2017CowenReiterated RatingBuy$95.00N/AView Rating Details
10/9/2017Leerink SwannReiterated RatingMarket Perform$88.00 -> $85.00N/AView Rating Details
10/9/2017Royal Bank of CanadaLower Price TargetOutperform -> Outperform$90.00 -> $85.00N/AView Rating Details
10/9/2017Wells Fargo & CompanyDowngradeOutperform -> Market Perform$93.00 -> $83.00N/AView Rating Details
8/23/2017BarclaysLower Price TargetOverweight$94.00 -> $92.00LowView Rating Details
7/31/2017Deutsche BankSet Price TargetBuy$96.00LowView Rating Details
7/6/2017William BlairReiterated RatingOutperformMediumView Rating Details
5/30/2017Morgan StanleyBoost Price TargetEqual Weight$84.00 -> $86.00LowView Rating Details
5/28/2017Evercore ISIReiterated RatingOutperform$88.50 -> $91.00LowView Rating Details
5/26/2017CIBCReiterated RatingBuyLowView Rating Details
5/16/2017Goldman Sachs GroupInitiated CoverageNeutral -> Neutral$87.00LowView Rating Details
3/20/2017BTIG ResearchReiterated RatingNeutralLowView Rating Details
2/22/2017WedbushReiterated RatingNeutral$85.00N/AView Rating Details
1/3/2017Bank of AmericaDowngradeBuy -> Neutral$78.00N/AView Rating Details
1/3/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$84.00 -> $79.00N/AView Rating Details
8/25/2016Credit Suisse GroupReiterated RatingOutperform$92.00N/AView Rating Details
8/23/2016CitigroupInitiated CoverageBuy$63.98 -> $102.00N/AView Rating Details
6/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$93.00 -> $94.00N/AView Rating Details
6/8/2016GuggenheimInitiated CoverageNeutralN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$86.00N/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Medtronic (NYSE:MDT) Earnings History and Estimates Chart

Earnings by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE MDT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/20/2018$1.17N/AView Earnings Details
11/21/2017Q2 18$0.99$1.07$7.05 billion$7.05 billionViewN/AView Earnings Details
8/22/20177/31/2017$1.08$1.12$7.44 billion$7.39 billionViewN/AView Earnings Details
5/25/2017Q4 17$1.31$1.33$7.86 billion$7.92 billionViewN/AView Earnings Details
2/21/20171/31/2017$1.11$1.12$7.22 billion$7.28 billionViewListenView Earnings Details
11/22/2016Q217$1.11$1.12$7.46 billion$7.35 billionViewListenView Earnings Details
8/25/2016Q117$1.01$1.03$7.17 billion$7.20 billionViewListenView Earnings Details
5/31/2016Q416$1.26$1.27$7.49 billion$7.57 billionViewListenView Earnings Details
3/1/2016Q316$1.06$1.06$6.99 billion$6.93 billionViewListenView Earnings Details
12/3/2015Q216$1.00$1.03$7.08 billion$7.06 billionViewListenView Earnings Details
9/3/2015Q116$1.01$1.02$7.03 billion$7.27 billionViewListenView Earnings Details
6/2/2015Q415$1.11$1.16$7.18 billion$7.30 billionViewListenView Earnings Details
2/17/2015Q3$0.97$1.01$4.25 million$4.32 millionViewListenView Earnings Details
11/18/2014Q2$0.96$0.96$4.37 million$4.40 millionViewListenView Earnings Details
8/19/2014Q115$0.92$0.93$4.25 billion$4.27 billionViewListenView Earnings Details
5/20/2014Q414$1.12$1.12$4.58 billion$4.60 billionViewListenView Earnings Details
2/18/2014Q314$0.91$0.91$4.15 billion$4.20 billionViewListenView Earnings Details
11/19/2013Q214$0.90$0.91$4.18 billion$4.20 billionViewListenView Earnings Details
8/20/2013Q1 2014$0.88$0.88$4.11 billion$4.10 billionViewListenView Earnings Details
5/21/2013Q4 2013$1.03$1.10$4.39 billion$4.50 billionViewListenView Earnings Details
2/19/2013Q3 2013$0.91$0.93$4.03 billion$4.03 billionViewListenView Earnings Details
11/20/20120.88$0.88$4.10 billionViewN/AView Earnings Details
8/21/2012$0.85$0.85ViewN/AView Earnings Details
5/22/2012$0.98$0.99ViewN/AView Earnings Details
2/21/2012$0.84$0.88ViewN/AView Earnings Details
11/22/2011$0.82$0.84ViewN/AView Earnings Details
8/23/2011$0.79$0.79ViewN/AView Earnings Details
5/24/2011$0.93$0.90ViewN/AView Earnings Details
2/22/2011$0.84$0.86ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Medtronic (NYSE:MDT) Earnings Estimates

2017 EPS Consensus Estimate: $4.62
2018 EPS Consensus Estimate: $4.74
2019 EPS Consensus Estimate: $5.22
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20177$1.00$1.15$1.03
Q2 20177$1.10$1.37$1.16
Q3 20177$1.10$1.15$1.12
Q4 20177$1.29$1.34$1.31
Q1 20186$1.07$1.15$1.10
Q2 20187$0.89$1.20$1.03
Q3 20187$1.15$1.24$1.19
Q4 20187$1.40$1.46$1.42
Q1 20194$1.16$1.24$1.21
Q2 20194$1.17$1.26$1.21
Q3 20194$1.27$1.34$1.30
Q4 20194$1.43$1.57$1.51
(Data provided by Zacks Investment Research)

Dividends

Medtronic (NYSE:MDT) Dividend Information

Next Dividend:1/19/2018
Annual Dividend:$1.84
Dividend Yield:2.24%
Dividend Growth:24.20% (3 Year Average)
Payout Ratio:50.41% (Trailing 12 Months of Earnings)
38.57% (Based on This Year's Estimates)
35.73% (Based on Next Year's Estimates)
Track Record:39 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/8/2017Quarterly$0.4612/28/201712/29/20171/19/2018
8/28/2017Quarterly$0.462.31%9/28/20179/29/201710/20/2017
6/23/2017Quarterly$0.462.07%7/5/20177/7/20177/26/2017
3/10/2017Quarterly$0.432.08%3/22/20173/24/20174/13/2017
12/9/2016quarterly$0.432.33%12/21/201612/23/20161/13/2017
8/22/2016Quarterly$0.431.98%9/27/20169/29/201610/21/2016
6/24/2016quarterly$0.431.85%7/6/20167/8/20167/27/2016
2/22/2016quarterly$0.381.98%3/22/20163/24/20164/15/2016
12/11/2015quarterly$0.381.96%12/22/201512/24/20151/15/2016
8/21/2015quarterly$0.382.18%9/23/20159/25/201510/16/2015
6/19/2015quarterly$0.381.97%6/25/20156/29/20157/17/2015
2/20/2015quarterly$0.311.55%3/26/20153/30/20154/17/2015
12/4/2014$0.3112/30/20141/2/20151/16/2015
12/5/2014quarterly$0.311.63%12/30/20141/2/20151/6/2015
8/21/2014quarterly$0.311.92%10/1/201410/3/201410/24/2014
6/16/2014quarterly$0.311.98%7/1/20147/3/20147/25/2014
2/14/2014quarterly$0.281.97%4/2/20144/4/20144/25/2014
12/5/2013quarterly$0.281.93%12/31/20131/3/20141/24/2014
8/22/2013quarterly$0.282.12%10/2/201310/4/201310/25/2013
6/21/2013quarterly$0.282.13%7/2/20137/5/20137/26/2013
2/15/2013quarterly$0.262.21%4/3/20134/5/20134/26/2013
12/9/2012quarterly$0.262.44%12/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Medtronic (NYSE MDT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.31%
Institutional Ownership Percentage: 81.86%
Insider Trades by Quarter for Medtronic (NYSE:MDT)
Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE MDT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2017Bryan C. HansonEVPSell16,000$79.02$1,264,320.00View SEC Filing  
10/16/2017Bryan C HansonEVPSell16,000$78.03$1,248,480.00View SEC Filing  
9/15/2017Omar IshrakCEOSell140,407$81.63$11,461,423.41View SEC Filing  
7/17/2017Bryan C. HansonEVPSell12,000$88.57$1,062,840.00View SEC Filing  
6/21/2017Richard H AndersonDirectorBuy5,600$88.90$497,840.00View SEC Filing  
3/20/2017Hoedt Rob TenEVPSell50,757$81.58$4,140,756.06View SEC Filing  
3/15/2017Omar IshrakCEOSell95,000$82.82$7,867,900.00View SEC Filing  
3/2/2017Hooman HakamiEVPSell52,316$82.33$4,307,176.28View SEC Filing  
12/13/2016Robert C. PozenDirectorBuy13,660$73.21$1,000,048.60View SEC Filing  
11/23/2016James T. LenehanDirectorBuy2,000$73.27$146,540.00View SEC Filing  
9/27/2016Richard KuntzVPSell17,141$86.70$1,486,124.70View SEC Filing  
9/26/2016Richard KuntzVPSell25,199$86.67$2,183,997.33View SEC Filing  
9/15/2016Kendall J. PowellDirectorSell7,907$85.45$675,653.15View SEC Filing  
9/15/2016Omar IshrakCEOSell61,925$84.93$5,259,290.25View SEC Filing  
8/29/2016Bryan C HansonEVPSell15,000$87.00$1,305,000.00View SEC Filing  
7/26/2016Bryan C HansonEVPSell15,000$87.00$1,305,000.00View SEC Filing  
7/15/2016Geoffrey MarthaEVPSell3,766$88.26$332,387.16View SEC Filing  
7/13/2016Gary Lee EllisEVPSell35,495$88.64$3,146,276.80View SEC Filing  
7/13/2016Shirley A JacksonDirectorSell2,104$88.64$186,498.56View SEC Filing  
7/6/2016Carol A. SurfaceSVPSell9,787$87.08$852,251.96View SEC Filing  
7/5/2016Bryan C. HansonEVPSell15,272$87.11$1,330,343.92View SEC Filing  
6/3/2016Richard KuntzVPSell49,905$82.60$4,122,153.00View SEC Filing  
4/1/2016Richard KuntzVPSell4,000$75.22$300,880.00View SEC Filing  
3/18/2016Shirley A JacksonDirectorSell1,238$75.60$93,592.80View SEC Filing  
3/17/2016Omar IshrakCEOSell23,799$76.15$1,812,293.85View SEC Filing  
3/4/2016Bryan C HansonEVPSell5,000$75.00$375,000.00View SEC Filing  
2/5/2016Bryan C. HansonEVPSell5,000$76.14$380,700.00View SEC Filing  
1/8/2016Bryan C HansonEVPSell5,000$75.00$375,000.00View SEC Filing  
12/4/2015Richard KuntzVPSell13,715$78.06$1,070,592.90View SEC Filing  
9/15/2015Omar IshrakCEOSell20,000$69.43$1,388,600.00View SEC Filing  
7/14/2015Carol A SurfaceSVPSell13,722$75.83$1,040,539.26View SEC Filing  
4/6/2015Richard KuntzVPSell31,768$77.39$2,458,525.52View SEC Filing  
3/25/2015Gary Lee EllisCFOSell43,183$77.81$3,360,069.23View SEC Filing  
3/13/2015Omar IshrakCEOSell20,000$76.24$1,524,800.00View SEC Filing  
2/19/2015Christopher J OconnellEVPSell50,361$78.22$3,939,237.42View SEC Filing  
12/19/2014Richard KuntzVPSell12,855$74.54$958,211.70View SEC Filing  
12/2/2014Shirley A JacksonDirectorSell1,102$74.43$82,021.86View SEC Filing  
11/28/2014Christopher J OconnellEVPSell42,921$73.95$3,174,007.95View SEC Filing  
10/6/2014Christopher J OconnellEVPSell15,388$64.98$999,912.24View SEC Filing  
8/26/2014Christopher J OconnellEVPSell28,000$63.57$1,779,960.00View SEC Filing  
8/26/2014Shirley A JacksonDirectorSell2,769$63.66$176,274.54View SEC Filing  
4/17/2014Catherine SzymanVPSell29,420$58.79$1,729,601.80View SEC Filing  
4/9/2014Richard KuntzVPSell2,512$60.98$153,181.76View SEC Filing  
4/1/2014Gary Lee EllisCFOSell4,246$61.48$261,044.08View SEC Filing  
3/28/2014Christopher OconnellEVPSell1,982$60.39$119,692.98View SEC Filing  
3/20/2014Catherine SzymanVPSell14,979$59.57$892,299.03View SEC Filing  
3/14/2014Omar IshrakCEOSell10,000$59.12$591,200.00View SEC Filing  
3/10/2014Neil AyotteVPSell1,845$59.64$110,035.80View SEC Filing  
12/4/2013Neil AyotteVPSell1,729$57.14$98,795.06View SEC Filing  
9/13/2013Omar IshrakCEOSell10,000$53.58$535,800.00View SEC Filing  
8/26/2013Catherine SzymanVPSell56,998$52.60$2,998,094.80View SEC Filing  
8/22/2013H James DallasVPSell32,332$53.19$1,719,739.08View SEC Filing  
8/21/2013H James DallasVPSell36,256$52.82$1,915,041.92View SEC Filing  
8/21/2013Shirley JacksonDirectorSell8,033$52.84$424,463.72View SEC Filing  
7/11/2013Christopher J OconnellEVPSell30,429$52.92$1,610,302.68View SEC Filing  
7/11/2013Gary Lee EllisCFOSell32,602$53.62$1,748,119.24View SEC Filing  
7/11/2013H James DallasVPSell69,889$53.72$3,754,437.08View SEC Filing  
7/1/2013H James DallasVPSell20,579$52.10$1,072,165.90View SEC Filing  
6/26/2013D Cameron FindlayVPSell75,042$52.20$3,917,192.40View SEC Filing  
6/19/2013H James DallasVPSell94,117$52.74$4,963,730.58View SEC Filing  
5/22/2013Richard H AndersonDirectorBuy4,800$52.32$251,136.00View SEC Filing  
5/10/2013Jack W SchulerDirectorSell34,230$48.24$1,651,255.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Medtronic (NYSE MDT) News Headlines

Source:
DateHeadline
Comparing Medtronic (MDT) & Arch Therapeutics (ARTH)Comparing Medtronic (MDT) & Arch Therapeutics (ARTH)
www.americanbankingnews.com - December 12 at 7:56 PM
Bullish Two Hundred Day Moving Average Cross - MDTBullish Two Hundred Day Moving Average Cross - MDT
www.nasdaq.com - December 12 at 5:21 PM
Medtronic Plc :MDT-US: Earnings Analysis: Q2, 2018 By the Numbers : December 12, 2017Medtronic Plc :MDT-US: Earnings Analysis: Q2, 2018 By the Numbers : December 12, 2017
finance.yahoo.com - December 12 at 5:21 PM
Argus Gives Medtronic Improved Prognosis, Expects Nearly 10% Future GrowthArgus Gives Medtronic Improved Prognosis, Expects Nearly 10% Future Growth
finance.yahoo.com - December 12 at 5:21 PM
Buy Medtronic on Strength Looking for Follow-Through BuyingBuy Medtronic on Strength Looking for Follow-Through Buying
finance.yahoo.com - December 12 at 5:21 PM
FDA proposes new fast path to market for certain medical devicesFDA proposes new fast path to market for certain medical devices
finance.yahoo.com - December 12 at 10:20 AM
Solid Earnings Momentum Metrics Drive Upgrade of Medtronic (MDT) to BuySolid Earnings Momentum Metrics Drive Upgrade of Medtronic (MDT) to Buy
investorplace.com - December 12 at 9:37 AM
Medtronic (MDT) Upgraded at ArgusMedtronic (MDT) Upgraded at Argus
www.americanbankingnews.com - December 12 at 8:52 AM
Medtronic PLC (MDT) Receives Average Rating of "Hold" from AnalystsMedtronic PLC (MDT) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 11 at 7:40 PM
Critical Survey: Arch Therapeutics (ARTH) versus Medtronic (MDT)Critical Survey: Arch Therapeutics (ARTH) versus Medtronic (MDT)
www.americanbankingnews.com - December 10 at 8:08 AM
Head to Head Contrast: Medtronic (MDT) vs. Integer (ITGR)Head to Head Contrast: Medtronic (MDT) vs. Integer (ITGR)
www.americanbankingnews.com - December 8 at 3:52 PM
Medtronic PLC (MDT) to Post Q3 2018 Earnings of $1.18 Per Share, Wedbush ForecastsMedtronic PLC (MDT) to Post Q3 2018 Earnings of $1.18 Per Share, Wedbush Forecasts
www.americanbankingnews.com - December 8 at 10:26 AM
Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2018Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2018
finance.yahoo.com - December 8 at 9:54 AM
WishBone Medical Inc. Names Jean-Pierre Capdevielle as Chief Strategy Officer and Board MemberWishBone Medical Inc. Names Jean-Pierre Capdevielle as Chief Strategy Officer and Board Member
feeds.benzinga.com - December 6 at 3:53 PM
Analyzing Arch Therapeutics (ARTH) and Medtronic (MDT)Analyzing Arch Therapeutics (ARTH) and Medtronic (MDT)
www.americanbankingnews.com - December 6 at 11:48 AM
Charting a bull-trend breakout, S&P 500 clears the 20-day volatility bandsCharting a bull-trend breakout, S&P 500 clears the 20-day volatility bands
www.marketwatch.com - December 5 at 4:55 PM
Ultimate Stock-Pickers: Top 10 Buys and SellsUltimate Stock-Pickers: Top 10 Buys and Sells
finance.yahoo.com - December 5 at 10:36 AM
Stock of Medtronic (MDT) Upgraded to Buy From a HoldStock of Medtronic (MDT) Upgraded to Buy From a Hold
investorplace.com - December 5 at 9:40 AM
Medtronic’s Recent Stock Price PerformanceMedtronic’s Recent Stock Price Performance
finance.yahoo.com - December 4 at 4:57 PM
Leerink Swann Weighs in on Medtronic PLCs Q1 2019 Earnings (MDT)Leerink Swann Weighs in on Medtronic PLC's Q1 2019 Earnings (MDT)
www.americanbankingnews.com - December 4 at 12:52 PM
How Expansion of Value-Based Contracts in CRM Affects MDT’s PricingHow Expansion of Value-Based Contracts in CRM Affects MDT’s Pricing
finance.yahoo.com - December 4 at 9:53 AM
Medtronic PLC (MDT) Forecasted to Earn FY2018 Earnings of $4.81 Per ShareMedtronic PLC (MDT) Forecasted to Earn FY2018 Earnings of $4.81 Per Share
www.americanbankingnews.com - December 1 at 9:48 PM
Medtronic’s Spine Business Dynamics amid a Challenging MarketMedtronic’s Spine Business Dynamics amid a Challenging Market
finance.yahoo.com - December 1 at 5:13 PM
How Medtronic Is Accelerating its Economic Value Strategy for GrowthHow Medtronic Is Accelerating its Economic Value Strategy for Growth
finance.yahoo.com - December 1 at 5:13 PM
Emerging Markets Growth Is Driving Medtronic’s Geographic StrategyEmerging Markets Growth Is Driving Medtronic’s Geographic Strategy
finance.yahoo.com - December 1 at 5:13 PM
Medtronic EVP & RTG President Geoff Martha to Speak at Citi Global Healthcare ConferenceMedtronic EVP & RTG President Geoff Martha to Speak at Citi Global Healthcare Conference
finance.yahoo.com - December 1 at 5:13 PM
Medtronic PLC (MDT) Expected to Announce Quarterly Sales of $7.18 BillionMedtronic PLC (MDT) Expected to Announce Quarterly Sales of $7.18 Billion
www.americanbankingnews.com - December 1 at 12:48 PM
How Medtronic Plans to Recover from Its Profit Decline in Fiscal 2Q18How Medtronic Plans to Recover from Its Profit Decline in Fiscal 2Q18
finance.yahoo.com - November 30 at 4:56 PM
These Strategies Are Expected to Drive BD’s GrowthThese Strategies Are Expected to Drive BD’s Growth
finance.yahoo.com - November 30 at 4:56 PM
Medtronic’s Disappointing MITG Business Performance in Fiscal 2Q18Medtronic’s Disappointing MITG Business Performance in Fiscal 2Q18
finance.yahoo.com - November 30 at 4:56 PM
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
finance.yahoo.com - November 30 at 10:23 AM
Medtronic PLC (MDT) Expected to Announce Earnings of $1.17 Per ShareMedtronic PLC (MDT) Expected to Announce Earnings of $1.17 Per Share
www.americanbankingnews.com - November 29 at 3:28 AM
Fewer Negatives Upgrade of Medtronic (MDT) to Hold - Investorplace.comFewer Negatives Upgrade of Medtronic (MDT) to Hold - Investorplace.com
www.investorplace.com - November 28 at 10:06 AM
Fewer Negatives Upgrade of Medtronic (MDT) to HoldFewer Negatives Upgrade of Medtronic (MDT) to Hold
investorplace.com - November 28 at 9:52 AM
Technical Perspectives on Edwards Lifesciences, Globus Medical, Invacare, and MedtronicTechnical Perspectives on Edwards Lifesciences, Globus Medical, Invacare, and Medtronic
www.bizjournals.com - November 27 at 4:59 PM
Medtronic Maintains Fiscal 2018 Guidance despite Natural DisastersMedtronic Maintains Fiscal 2018 Guidance despite Natural Disasters
finance.yahoo.com - November 27 at 4:59 PM
Medtronic Launches New Telehealth Solutions in Support of U.S. Department of Veterans Affairs National ContractMedtronic Launches New Telehealth Solutions in Support of U.S. Department of Veterans Affairs National Contract
finance.yahoo.com - November 27 at 4:59 PM
How Did Medtronic’s Segments Perform in Fiscal 2018?How Did Medtronic’s Segments Perform in Fiscal 2018?
finance.yahoo.com - November 27 at 4:59 PM
IRS presses $1.4 billion tax fight against MedtronicIRS presses $1.4 billion tax fight against Medtronic
finance.yahoo.com - November 27 at 4:59 PM
Q3 2018 EPS Estimates for Medtronic PLC Increased by Oppenheimer (MDT)Q3 2018 EPS Estimates for Medtronic PLC Increased by Oppenheimer (MDT)
www.americanbankingnews.com - November 27 at 7:42 AM
Medtronic’s 2Q18 Earnings Surpassed Analysts’ EstimatesMedtronic’s 2Q18 Earnings Surpassed Analysts’ Estimates
finance.yahoo.com - November 25 at 9:37 AM
Financial Review: Integer Holdings Corporation (ITGR) vs. Medtronic PLC (MDT)Financial Review: Integer Holdings Corporation (ITGR) vs. Medtronic PLC (MDT)
www.americanbankingnews.com - November 25 at 9:26 AM
Divestiture and Natural Disasters Hurt MDT’s Sales PerformanceDivestiture and Natural Disasters Hurt MDT’s Sales Performance
finance.yahoo.com - November 24 at 5:19 PM
SunTrust Banks Comments on Medtronic PLCs Q3 2019 Earnings (MDT)SunTrust Banks Comments on Medtronic PLC's Q3 2019 Earnings (MDT)
www.americanbankingnews.com - November 23 at 8:50 PM
Q4 2018 EPS Estimates for Medtronic PLC Cut by Oppenheimer Holdings (MDT)Q4 2018 EPS Estimates for Medtronic PLC Cut by Oppenheimer Holdings (MDT)
www.americanbankingnews.com - November 23 at 7:04 PM
Jefferies Group Weighs in on Medtronic PLCs FY2018 Earnings (MDT)Jefferies Group Weighs in on Medtronic PLC's FY2018 Earnings (MDT)
www.americanbankingnews.com - November 23 at 4:06 PM
Medtronic PLC (MDT) Rating Reiterated by Jefferies Group LLCMedtronic PLC (MDT) Rating Reiterated by Jefferies Group LLC
www.americanbankingnews.com - November 23 at 4:00 PM
Medtronic PLCs (MDT) Hold Rating Reaffirmed at Northland SecuritiesMedtronic PLC's (MDT) Hold Rating Reaffirmed at Northland Securities
www.americanbankingnews.com - November 23 at 3:18 PM
Medtronic PLC (MDT) Upgraded to "Hold" at Zacks Investment ResearchMedtronic PLC (MDT) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - November 23 at 2:34 PM
Q3 2018 EPS Estimates for Medtronic PLC Lifted by Analyst (MDT)Q3 2018 EPS Estimates for Medtronic PLC Lifted by Analyst (MDT)
www.americanbankingnews.com - November 23 at 2:22 PM

SEC Filings

Medtronic (NYSE:MDT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Medtronic (NYSE:MDT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medtronic (NYSE MDT) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.